Does lower androgen tone in women lead to reduced muscle, increased fat, and worse insulin sensitivity?

The maintenance of metabolic health in women involves a precise hormonal balance where androgens—often overlooked in female physiology—play a critical role in regulating body composition and glucose metabolism. For women in the postmenopausal transition, the decline in androgenic activity contributes to a shift in physical phenotype that directly impacts systemic insulin sensitivity.

Clinical evidence and body composition

Androgens, including testosterone and DHEA, are essential for the maintenance of lean body mass. Research suggests a significant correlation between androgen levels and muscle protein synthesis; in postmenopausal populations, lower bioavailable testosterone is frequently associated with sarcopenia and reduced skeletal muscle strength. Conversely, clinical trials using physiological testosterone replacement in androgen-deficient women have demonstrated improvements in lean mass and resting energy expenditure. The relationship with adiposity is equally significant; lower androgen tone is observationally linked to increased visceral fat and total body adiposity. While high androgen levels (as seen in PCOS) are detrimental, a baseline "androgenic tone" appears necessary to inhibit adipogenesis and promote lipid oxidation.

Mechanistic explanations

The progression from altered body composition to insulin resistance is driven by two primary physiological mechanisms:

• Reduced Glucose Disposal: Skeletal muscle accounts for approximately 80% of postprandial glucose uptake. A reduction in lean mass inherently limits the capacity for insulin-mediated glucose disposal. This is further exacerbated by the downregulation of GLUT4 translocation and impaired signaling in the PI3K/Akt pathway within existing muscle fibers.
• Adipokine Signaling: Increased fat mass, particularly visceral adipose tissue, functions as an active endocrine organ. It releases pro-inflammatory cytokines such as TNF-alpha and IL-6, which interfere with insulin receptor substrate (IRS-1) signaling, creating a state of systemic insulin resistance.

Bottom line

Low androgen tone contributes to a "sarcopenic obesity" phenotype—reduced muscle and increased fat—which significantly worsens insulin sensitivity. For postmenopausal women, this hormonal shift increases the risk of metabolic dysfunction, emphasizing the importance of maintaining muscle mass through resistance training or hormonal optimization to preserve glucose homeostasis.